| scholarly article | Q13442814 |
| P50 | author | Julia C Cutts | Q85271181 |
| P2093 | author name string | Julie A Simpson | |
| Freya J I Fowkes | |||
| Paul A Agius | |||
| Zaw Lin | |||
| Kerryn Moore | |||
| Rosanna Powell | |||
| Bridget Draper | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| Analysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolates | Q24792921 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1 | Q27973758 | ||
| Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria | Q27976511 | ||
| Var2CSA minimal CSA binding region is located within the N-terminal region | Q28744428 | ||
| What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes | Q29615705 | ||
| Antigen reversal identifies targets of opsonizing IgGs against pregnancy-associated malaria | Q30603697 | ||
| Disruption of var2csa gene impairs placental malaria associated adhesion phenotype | Q33299476 | ||
| The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis | Q33526349 | ||
| Differential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area | Q33532592 | ||
| Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria | Q33593182 | ||
| Functional antibodies against VAR2CSA in nonpregnant populations from colombia exposed to Plasmodium falciparum and Plasmodium vivax | Q33603038 | ||
| Rapid acquisition of isolate-specific antibodies to chondroitin sulfate A-adherent plasmodium falciparum isolates in Ghanaian primigravidae | Q33769097 | ||
| Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women | Q33826049 | ||
| Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens | Q33883435 | ||
| Antibodies that induce phagocytosis of malaria infected erythrocytes: effect of HIV infection and correlation with clinical outcomes | Q33980021 | ||
| Development of antibodies against chondroitin sulfate A-adherent Plasmodium falciparum in pregnant women | Q34002177 | ||
| The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes | Q38377287 | ||
| Developing vaccines to prevent malaria in pregnant women | Q38519513 | ||
| Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight | Q39342937 | ||
| Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae | Q39460324 | ||
| Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi. | Q39489373 | ||
| Decreasing malaria prevalence and its potential consequences for immunity in pregnant women | Q39517373 | ||
| Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women. | Q39537046 | ||
| Clinical development of a VAR2CSA-based placental malaria vaccine PAMVAC: Quantifying vaccine antigen-specific memory B & T cell activity in Beninese primigravidae | Q40204991 | ||
| Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens | Q40208028 | ||
| VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria | Q40670564 | ||
| Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. | Q41919160 | ||
| Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis | Q41992385 | ||
| Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens | Q41992842 | ||
| Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum | Q42273010 | ||
| Ultrastructural localization of glycosaminoglycans in human term placenta | Q42444837 | ||
| P. falciparum infection and maternofetal antibody transfer in malaria-endemic settings of varying transmission | Q42701669 | ||
| Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment | Q43115857 | ||
| Low antibody levels to pregnancy-specific malaria antigens and heightened cytokine responses associated with severe malaria in pregnancy | Q44768596 | ||
| Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta | Q45249046 | ||
| The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A. | Q46326711 | ||
| Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria | Q47232540 | ||
| Massive chronic intervillositis of the placenta associated with malaria infection. | Q47835217 | ||
| Maternal antibodies block malaria | Q47838841 | ||
| Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A. | Q47871002 | ||
| Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes | Q47921599 | ||
| Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies | Q47999224 | ||
| VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum | Q48028019 | ||
| Cytoadherence characteristics of Plasmodium falciparum isolates from Thailand: evidence for chondroitin sulfate a as a cytoadherence receptor | Q48029136 | ||
| Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes. | Q54258919 | ||
| Association of Antibodies to VAR2CSA and Merozoite Antigens with Pregnancy Outcomes in Women Living in Yaoundé, Cameroon | Q56341834 | ||
| IgG Responses to the Plasmodium falciparum Antigen VAR2CSA in Colombia Are Restricted to Pregnancy and Are Not Induced by Exposure to Plasmodium vivax | Q56358725 | ||
| Global genetic diversity of var2csa in Plasmodium falciparum with implications for malaria in pregnancy and vaccine development | Q57890692 | ||
| Immune effector mechanisms in malaria | Q82383609 | ||
| Targeting Pregnant Women for Malaria Surveillance | Q92506817 | ||
| Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy | Q34009705 | ||
| Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies | Q34095324 | ||
| High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria | Q34326742 | ||
| Evidence for the involvement of VAR2CSA in pregnancy-associated malaria | Q34364093 | ||
| Designing a VAR2CSA-based vaccine to prevent placental malaria | Q34498103 | ||
| Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy | Q34740303 | ||
| Plasmodial pigmentation of placenta and outcome of pregnancy in West African mothers | Q34994493 | ||
| The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site | Q35088554 | ||
| Cytoadherence of Plasmodium falciparum to intercellular adhesion molecule 1 and chondroitin-4-sulfate expressed by the syncytiotrophoblast in the human placenta | Q35545174 | ||
| Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin | Q35546075 | ||
| The sick placenta-the role of malaria. | Q35744707 | ||
| High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission | Q35867607 | ||
| Placental pathologic changes in malaria. A histologic and ultrastructural study | Q35885258 | ||
| Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study | Q35942403 | ||
| Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria. | Q36078717 | ||
| Malaria during Pregnancy | Q36284603 | ||
| New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women | Q36330969 | ||
| Comparison of the specificity of antibodies to VAR2CSA in Cameroonian multigravidae with and without placental malaria: a retrospective case-control study | Q36336978 | ||
| The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1. | Q36339851 | ||
| Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes | Q36365076 | ||
| Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns | Q36374795 | ||
| Differential evolution of anti-VAR2CSA- IgG3 in primigravidae and multigravidae pregnant women infected by Plasmodium falciparum | Q36478193 | ||
| Epidemiology and burden of malaria in pregnancy | Q36717617 | ||
| Malaria in pregnancy: pathogenesis and immunity | Q36717621 | ||
| Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study | Q36809595 | ||
| Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development | Q36984161 | ||
| Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties | Q37036123 | ||
| Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets | Q37036128 | ||
| Interpretation of tests of heterogeneity and bias in meta-analysis | Q37329334 | ||
| ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions | Q37335426 | ||
| Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy | Q37382365 | ||
| Association between malaria immunity and pregnancy outcomes among Malawian pregnant women receiving nutrient supplementation | Q37406034 | ||
| Malaria, primigravidae, and antibodies: knowledge gained and future perspectives | Q38175603 | ||
| P433 | issue | 1 | |
| P921 | main subject | malaria | Q12156 |
| systematic review | Q1504425 | ||
| pregnancy-associated malaria | Q7239883 | ||
| P304 | page(s) | 14 | |
| P577 | publication date | 2020-01-16 | |
| P1433 | published in | BMC Medicine | Q4835947 |
| P1476 | title | Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review | |
| P478 | volume | 18 |
| Q99582268 | Placental Malaria | cites work | P2860 |
Search more.